Market Research Logo

Cough, Cold and Allergy (Hay Fever) Remedies in Australia

Cough, Cold and Allergy (Hay Fever) Remedies in Australia

Whilst the ban on OTC sales of codeine, due to come into effect from February 2018, will hit analgesics the hardest, the ban is also expected to impact growth in cough, cold and allergy remedies over the forecast period, with manufacturers including codeine in certain combination products. In December 2016, Australia’s drug regulator, the Therapeutic Goods Administration (TGA), shifted painkillers containing codeine from schedule two or schedule three to schedule four starting from February 2018...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.


COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
Euromonitor International
October 2017
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Ban on OTC Codeine From February 2018
the Effect on Existing Brands and the Launch of New Brands
Manufacturers Active in New Product Development in Pharyngeal Preparations
Competitive Landscape
Johnson & Johnson Pacific Pty Ltd Maintains Its Lead
Multinationals Dominate
Nasonex's Switch Supports Growth in Nasal Sprays
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 3 Sales of Decongestants by Category: Value 2012-2017
Table 4 Sales of Decongestants by Category: % Value Growth 2012-2017
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Delivers Modest Growth
Crackdown on OTC Codeine
Mergers and Acquisitions Are Commonplace in Consumer Health
Discount Pharmacies Continue To See An Increasing Share
Amazon's Entrance Set To Shake-up the Market
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 10 Life Expectancy at Birth 2012-2017
Market Data
Table 11 Sales of Consumer Health by Category: Value 2012-2017
Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Definitions
Sources
Summary 2 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report